NovaBay Pharmaceuticals, Inc.
NovaBay Pharmaceuticals, Inc. (NBY) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · NBY · as of Jun 8, 2026
Activity summary
Buy transactions
36
P-Purchase only
Sell transactions
1
12 Months
Buy/Sell ratio
36.00
Buy/Sell (by trades)
Overall sentiment
NovaBay Pharmaceuticals, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
NBY insider buying and selling by quarter
NBY insider selling · NBY insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · NBY ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
NBY executive sell shares · NBY board member insider trading · NBY insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 21, 2025 | Lazar David E. 10 percent owner | Award | 6,388,000 | — | Form 4 |
| Oct 21, 2025 | Framework Ventures IV L.P. 10 percent owner | Other | 56,806,080 | — | Form 4 |
| Oct 21, 2025 | R01 Fund LP 10 percent owner | Other | 56,806,080 | — | Form 4 |
| Oct 21, 2025 | Kazley Michael John CEO · Director | Other | 56,806,080 | — | Form 4 |
| May 11, 2023 | Freiman Paul E. Director | Option | 858 | — | Form 4 |
| May 11, 2023 | Zheng Yenyou Director | Option | 858 | — | Form 4 |
| May 11, 2023 | WU MIJIA Director | Option | 858 | — | Form 4 |
| May 11, 2023 | Sit Swan Director | Option | 858 | — | Form 4 |
| May 11, 2023 | Garlikov Julie Director | Option | 858 | — | Form 4 |
| May 11, 2023 | Zheng Yongxiang Director | Option | 858 | — | Form 4 |
| Dec 6, 2022 | Kunin Audrey Chief Product Officer | Sale | 1 | $2 | Form 4 |
| Dec 6, 2022 | Kunin Jeffrey President, DERMAdoctor, LLC | Sale | 1 | $2 | Form 4 |
| Nov 21, 2022 | Kunin Audrey Chief Product Officer | Sale | 5,960 | $13K | Form 4 |
| Nov 21, 2022 | Kunin Jeffrey President, DERMAdoctor, LLC | Sale | 5,960 | $13K | Form 4 |
| Sep 14, 2022 | Hall Justin CEO, GC and Director | Purchase | 10,000 | $2K | Form 4 |
| May 21, 2022 | Zheng Yenyou Director | Option | 30,000 | — | Form 4 |
| May 21, 2022 | Sit Swan Director | Option | 30,000 | — | Form 4 |
Framework Ventures IV L.P.
10 percent owner
Date
Oct 21
Shares
56,806,080
Price
—
Value
—
Kunin Jeffrey
President, DERMAdoctor, LLC
Date
Nov 21
Shares
5,960
Price
$2.10
Value
$13K
Hall Justin
CEO, GC and Director
Date
Sep 14
Shares
10,000
Price
$0.15
Value
$2K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About NBY insider trading
NBY insider trades
NovaBay Pharmaceuticals, Inc. (NBY) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Lazar David E. (10 percent owner), Framework Ventures IV L.P. (10 percent owner), R01 Fund LP (10 percent owner). Over the past 12 months, 4 insiders have filed transactions with the SEC. NBY insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For NovaBay Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
NBY insider trading · 5 questionsThe insiders of NovaBay Pharmaceuticals, Inc. (NBY) include executives and directors such as Lazar David E. (10 percent owner), Framework Ventures IV L.P. (10 percent owner), R01 Fund LP (10 percent owner), among others. Over the past 12 months, 4 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026